Publication Date:
2018
Description:
Pediatric drug–drug interactions (DDIs) can be life threatening, and a plan for assessing the interaction potential should be part of every pediatric drug development program. However, DDI studies are rarely performed in the pediatric population for ethical and practical reasons. Consequently, there is a paucity of information available regarding pediatric DDIs. This article will propose strategies for evaluating pharmacokinetic/pharmacodynamic DDIs throughout pediatric drug development and clinical use.
Print ISSN:
0009-9236
Electronic ISSN:
1532-6535
Topics:
Chemistry and Pharmacology
,
Medicine
Permalink